J. Puig-Barberá

发表

2011–12 Seasonal Influenza Vaccines Effectiveness against Confirmed A(H3N2) Influenza Hospitalisation: Pooled Analysis from a European Network of Hospitals. A Pilot Study

S. Costanzo, J. Castilla, O. Launay, 2013, PloS one.

Herpes zoster surveillance using electronic databases in the Valencian Community (Spain)

J. Díez-Domingo, J. Puig-Barberá, Nuria Morant-Talamante, 2013, BMC Infectious Diseases.

Epidemiology of Herpes Zoster Infection among Patients Treated in Primary Care Centres in the Valencian Community (Spain)

J. Díez-Domingo, J. Puig-Barberá, J. Navarro-Pérez, 2010, BMC family practice.

Influenza Vaccine Effectiveness and Waning Effect in Hospitalized Older Adults. Valencia Region, Spain, 2018/2019 Season

M. Tortajada-Girbés, F. López-Labrador, J. García-Rubio, 2021, International journal of environmental research and public health.

Influenza vaccine effectiveness against laboratory-confirmed influenza in hospitalised adults aged 60 years or older, Valencia Region, Spain, 2017/18 influenza season

M. Tortajada-Girbés, F. López-Labrador, J. Díez-Domingo, 2019, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Influenza vaccine effectiveness in preventing hospitalisation of individuals 60 years of age and over with laboratory-confirmed influenza, Valencia Region, Spain, influenza season 2016/17

M. Tortajada-Girbés, F. López-Labrador, J. Díez-Domingo, 2018, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Influenza vaccine effectiveness in preventing hospitalization among Beijing residents in China, 2013-15.

Peng Wu, B. Cowling, Hongjie Yu, 2016, Vaccine.

Varicella Vaccine Effectiveness During an Outbreak in a Partially Vaccinated Population in Spain

A. Arnedo-Pena, J. Puig-Barberá, J. Bellido-Blasco, 2006, The Pediatric infectious disease journal.

Relative Effectiveness of Cell-Cultured versus Egg-Based Seasonal Influenza Vaccines in Preventing Influenza-Related Outcomes in Subjects 18 Years Old or Older: A Systematic Review and Meta-Analysis

P. Plans-Rubió, J. Puig-Barberá, Sonia Tamames-Gómez, 2021 .

National influenza surveillance systems in five European countries: a qualitative comparative framework based on WHO guidance

S. de Lusignan, P. Vanhems, E. Pariani, 2022, BMC Public Health.

Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis

S. Madhi, H. Zar, A. Gebremedhin, 2022, The Lancet.

Review of Analyses Estimating Relative Vaccine Effectiveness of Cell-Based Quadrivalent Influenza Vaccine in Three Consecutive US Influenza Seasons

J. Ortiz, J. Puig-Barberá, Mendel Haag, 2022, Vaccines.

Relative Effectiveness of MF59 Adjuvanted Trivalent Influenza Vaccine vs Nonadjuvanted Vaccines During the 2019–2020 Influenza Season

Mahrukh Imran, J. Ortiz, J. Puig-Barberá, 2022, Open forum infectious diseases.

2010-2011 influenza seasonal vaccine, preliminary mid-season effectiveness estimates: reason for concern, confounding or are we following the right track?

J. Puig-Barberá, 2011, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Acceptability of human papillomavirus vaccine in mothers from Valencia (Spain)

J. Tuells, J. Díez-Domingo, J. Puig-Barberá, 2015 .

Acceptability of human papillomavirus vaccine in mothers from Valencia (Spain)

J. Tuells, J. Díez-Domingo, J. Puig-Barberá, 2015 .

Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults.

Shinn-Jang Hwang, M. Levin, T. Vesikari, 2015, The New England journal of medicine.

A comparison of coronavirus disease 2019 and seasonal influenza surveillance in five European countries: France, Germany, Italy, Spain and the United Kingdom

P. Vanhems, E. Pariani, F. Ansaldi, 2021, Influenza and other respiratory viruses.

Intussusception following rotavirus vaccination in the Valencia Region, Spain

R. Gil-Prieto, J. Díez-Domingo, J. Puig-Barberá, 2015, Human vaccines & immunotherapeutics.

Risk factors and prevalence of asthma in schoolchildren in Castellon (Spain): a cross-sectional study.

A. Arnedo-Pena, J. Puig-Barberá, J. Bellido-Blasco, 2009, Allergologia et immunopathologia.

Retrospective screening for SARS-CoV-2 among 5,800 hospitalizations related to influenza-like illness during the 2018-19 pre-pandemic and 2019-2020 pandemic influenza seasons in the VAHNSI network, Spain.

M. Tortajada-Girbés, F. López-Labrador, J. García-Rubio, 2021, medRxiv.

Immunogenicity and Safety of Three Doses of a Bivalent (B:4:P1.19,15 and B:4:P1.7-2,4) Meningococcal Outer Membrane Vesicle Vaccine in Healthy Adolescents

J. Poolman, J. Findlow, R. Borrow, 2006, Clinical and Vaccine Immunology.

[Pneumococcal vaccine effectiveness in the elderly. Systematic review and meta-analysis].

J. Puig-Barberá, Á. Belenguer Varea, M. G. Goterris Pinto, 2002, Atencion primaria.

[Immunization: leaps into the future. Combined vaccines (II)].

J. Puig-Barberá, J. Díez Domingo, 2003, Atencion primaria.

Persistence of Anti-SARS-CoV-2 Antibodies Six Months After Infection in an Outbreak With Five Hundred COVID-19 Cases in Borriana (Spain): A Prospective Cohort Study

A. Arnedo-Pena, J. Puig-Barberá, M. R. Pac-Sa, 2021, COVID.

Pertussis in adults with persistent cough: a prospective follow up study in primary care

S. Pérez-Hoyos, J. Díez-Domingo, J. Puig-Barberá, 2009 .

Relative Vaccine Effectiveness of Adjuvanted Trivalent Influenza Vaccine over Three Consecutive Influenza Seasons in the United States

J. Ortiz, J. Puig-Barberá, Mendel Haag, 2022, Vaccines.

Seroprevalence of antibodies against serogroup C meningococci in the region of Valencia, Spain: Impact of meningococcal C conjugate vaccination.

M. Martínez-Beneito, J. Díez-Domingo, J. Puig-Barberá, 2017, Vaccine.

Influenza epidemiology and influenza vaccine effectiveness during the 2014–2015 season: annual report from the Global Influenza Hospital Surveillance Network

M. Tortajada-Girbés, Peng Wu, B. Cowling, 2016, BMC Public Health.

Addressing COVID-19 vaccine hesitancy

Ö. Türeci, J. Puig-Barberá, G. Kassianos, 2022, Drugs in context.

Respiratory syncytial virus infection in adults diagnosed in Valencian Region of Spain.

J. Díez-Domingo, J. Puig-Barberá, R. Doménech-Clar, 2016, Revista clinica espanola.

Influenza vaccine effectiveness against influenza-associated hospitalization in 2015/16 season, Beijing, China.

Peng Wu, B. Cowling, Hongjie Yu, 2017, Vaccine.

Influenza vaccine effectiveness in preventing hospitalization among 1 Beijing residents in China , 2013-15 2

Peng Wu, B. Cowling, Hongjie Yu, 2016 .

Seroprevalence Study and Cross-Sectional Survey on COVID-19 for a Plan to Reopen the University of Alicante (Spain)

J. Tuells, P. Zapater, J. Puig-Barberá, 2021, International journal of environmental research and public health.

Title: Persistence of anti-SARS-CoV-2 antibodies six months after infection in an outbreak with five hundred COVID-19 cases in Borriana (Spain): A prospective cohort study. Authors:

Lorna, Mercedes, A. Arnedo-Pena, 2021 .

Waning protection of influenza vaccination during four influenza seasons, 2011/2012 to 2014/2015.

M. Tortajada-Girbés, V. Gil-Guillén, F. López-Labrador, 2017, Vaccine.

Efficacy of the Herpes Zoster Subunit Vaccine in Adults 70 Years of Age or Older.

Lidia Oostvogels, Jan Smetana, Daisuke Watanabe, 2016, The New England journal of medicine.

Retrospective screening for SARS‐CoV‐2 among influenza‐like illness hospitalizations: 2018–2019 and 2019–2020 seasons, Valencia region, Spain

M. Tortajada-Girbés, F. López-Labrador, J. García-Rubio, 2021, Influenza and other respiratory viruses.

Epidemiology and cost of herpes zoster and postherpetic neuralgia among patients treated in primary care centres in the valencian community of Spain

J. Díez-Domingo, J. Puig-Barberá, J. Navarro-Pérez, 2011, BMC infectious diseases.

Intradermal and virosomal influenza vaccines for preventing influenza hospitalization in the elderly during the 2011-2012 influenza season: a comparative effectiveness study using the Valencia health care information system.

J. Díez-Domingo, J. Calabuig-Pérez, J. Puig-Barberá, 2014, Vaccine.

Influenza epidemiology and influenza vaccine effectiveness during the 2016–2017 season in the Global Influenza Hospital Surveillance Network (GIHSN)

S. Madhi, P. Koul, M. Tortajada-Girbés, 2019, BMC Public Health.

Effectiveness of influenza vaccination programme in preventing hospital admissions, Valencia, 2014/15 early results.

M. Tortajada-Girbés, J. Tuells, V. Gil-Guillén, 2015, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Effectiveness of MF59-adjuvanted seasonal influenza vaccine in the elderly: A systematic review and meta-analysis.

A. Domnich, R. Gasparini, D. Amicizia, 2017, Vaccine.

Global burden of acute lower respiratory infection associated with human metapneumovirus in children under 5 years in 2018: a systematic review and modelling study

M. Lucero, S. Madhi, K. O'Brien, 2020, The Lancet. Global health.

ABO Blood Groups and the Incidence of Complications in COVID-19 Patients: A Population-Based Prospective Cohort Study

A. Arnedo-Pena, J. Puig-Barberá, M. R. Pac-Sa, 2021, International journal of environmental research and public health.

Appropriateness of clopidogrel use according to current recommendations.

V. Gil-Guillén, D. Orozco-Beltrán, J. Puig-Barberá, 2014, Family practice.

“Knowledge and attitudes of Spanish adolescent girls towards human papillomavirus infection: where to intervene to improve vaccination coverage”

J. Tuells, J. Díez-Domingo, J. Puig-Barberá, 2014, BMC Public Health.

[Post-licensure passive safety surveillance of rotavirus vaccines: reporting sensitivity for intussusception].

J. Díez-Domingo, J. Puig-Barberá, S. Perez-Vilar, 2014 .

Role of age and birth month in infants hospitalized with RSV‐confirmed disease in the Valencia Region, Spain

M. Tortajada-Girbés, F. López-Labrador, J. García-Rubio, 2021, Influenza and other respiratory viruses.

Influenza Control in the 21st Century: Optimizing Protection of Older Adults

A. Monto, K. Nichol, L. Montaño, 2022 .

2012-2013 Seasonal Influenza Vaccine Effectiveness against Influenza Hospitalizations: Results from the Global Influenza Hospital Surveillance Network

A. Sominina, O. Launay, M. Ciblak, 2014, PloS one.

MF59™-adjuvanted seasonal influenza vaccine in young children

J. Díez-Domingo, J. Puig-Barberá, S. Perez-Vilar, 2011, Expert review of vaccines.

Repeated seasonal influenza vaccination among elderly in Europe: Effects on laboratory confirmed hospitalised influenza.

C. Rizzo, S. Costanzo, J. Castilla, 2017, Vaccine.

Effectiveness of MF59-adjuvanted subunit influenza vaccine in preventing hospitalisations for cardiovascular disease, cerebrovascular disease and pneumonia in the elderly.

J. Díez-Domingo, J. Puig-Barberá, D. G. Vidal, 2007, Vaccine.

Effectiveness of the MF59-adjuvanted influenza vaccine in preventing emergency admissions for pneumonia in the elderly over 64 years of age.

J. Díez-Domingo, J. Puig-Barberá, David González Vidal, 2004, Vaccine.

Pharmacoeconomic assessment of implementing a universal PCV-13 vaccination programme in the Valencian public health system (Spain).

M. Ridao-López, J. Díez-Domingo, J. Puig-Barberá, 2011, Vaccine.

Epidemiology of Hospital Admissions with Influenza during the 2013/2014 Northern Hemisphere Influenza Season: Results from the Global Influenza Hospital Surveillance Network

B. Cowling, Hongjie Yu, M. Pisareva, 2016, PloS one.

Low influenza vaccine effectiveness and the effect of previous vaccination in preventing admission with A(H1N1)pdm09 or B/Victoria-Lineage in patients 60 years old or older during the 2015/2016 influenza season.

M. Tortajada-Girbés, F. López-Labrador, J. Díez-Domingo, 2017, Vaccine.

Reduction in hospital admissions for pneumonia in non-institutionalised elderly people as a result of influenza vaccination: a case-control study in Spain.

J. Puig-Barberá, M. Gil-Martin, S. Márquez-Calderón, 1997, Journal of epidemiology and community health.

Complications Post-COVID-19 and Risk Factors among Patients after Six Months of a SARS-CoV-2 Infection: A Population-Based Prospective Cohort Study

A. Arnedo-Pena, J. Puig-Barberá, M. R. Pac-Sa, 2022, Epidemiolgia.

ANTIBODY PERSISTENCE 12 MONTHS AFTER A BOOSTER DOSE OF MENINGOCOCCAL-C CONJUGATED VACCINE IN THE SECOND YEAR OF LIFE

J. Díez-Domingo, J. Puig-Barberá, M. V. Gutiérrez-Gimeno, 2010, The Pediatric infectious disease journal.

The Global Influenza Hospital Surveillance Network (GIHSN): a new platform to describe the epidemiology of severe influenza

B. Cowling, Hongjie Yu, M. Pisareva, 2015, Influenza and other respiratory viruses.

Global Influenza Hospital-based Surveillance Network (GIHSN): results of surveillance of influenza and other respiratory viruses in hospitalised patients in Brazil, 2015

V. Picot, M. Siqueira, F. Moura, 2018, BMJ Open.

Production of Vegetables and Artichokes Is Associated with Lower Cardiovascular Mortality: An Ecological Study

F. Guillén-Grima, A. Arnedo-Pena, J. Puig-Barberá, 2020, International journal of environmental research and public health.

Influenza Vaccine Effectiveness in Preventing Influenza A(H3N2)-Related Hospitalizations in Adults Targeted for Vaccination by Type of Vaccine: A Hospital-Based Test-Negative Study, 2011–2012 A(H3N2) Predominant Influenza Season, Valencia, Spain

M. Tortajada-Girbés, A. Arnedo-Pena, V. Gil-Guillén, 2014, PloS one.

Population-based Analysis of Bronchiolitis Epidemiology in Valencia, Spain

J. Díez-Domingo, J. Puig-Barberá, S. Perez-Vilar, 2016, The Pediatric infectious disease journal.

2012/13 influenza vaccine effectiveness against hospitalised influenza A(H1N1)pdm09, A(H3N2) and B: estimates from a European network of hospitals.

E. Hak, S. Costanzo, F. Galtier, 2015, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[Domestic water hardness and prevalence of atopic eczema in Castellon (Spain) school children].

A. Arnedo-Pena, J. Puig-Barberá, J. Bellido-Blasco, 2007, Salud publica de Mexico.

Atopic dermatitis incidence and risk factors in young adults in Castellon (Spain): A prospective cohort study.

A. Arnedo-Pena, J. Puig-Barberá, J. Bellido-Blasco, 2020, Allergologia et immunopathologia.

Effectiveness of seasonal 2008-2009, 2009-2010 and pandemic vaccines, to prevent influenza hospitalizations during the autumn 2009 influenza pandemic wave in Castellón, Spain. A test-negative, hospital-based, case-control study.

Alberto Arnedo-Pena, A. Arnedo-Pena, J. Puig-Barberá, 2010, Vaccine.

Influenza epidemiology and influenza vaccine effectiveness during the 2015–2016 season: results from the Global Influenza Hospital Surveillance Network

P. Koul, B. Cowling, J. Kynčl, 2019, BMC Infectious Diseases.

Relative Effectiveness of Cell-Cultured versus Egg-Based Seasonal Influenza Vaccines in Preventing Influenza-Related Outcomes in Subjects 18 Years Old or Older: A Systematic Review and Meta-Analysis

P. Plans-Rubió, J. Puig-Barberá, Sonia Tamames-Gómez, 2021, International journal of environmental research and public health.

Safety and immunogenicity of a glycoprotein D genital herpes vaccine in healthy girls 10-17 years of age: results from a randomised, controlled, double-blind trial.

P. van Damme, D. Bernstein, J. Richardus, 2013, Vaccine.

MF59-adjuvanted and virosomal influenza vaccines for preventing influenza hospitalization in older people: comparative effectiveness using the Valencia health care information system.

J. Díez-Domingo, J. Calabuig-Pérez, J. Puig-Barberá, 2013, Vaccine.

Effectiveness of pneumococcal vaccine in the elderly . Review of the literature and meta-analysis

J. Puig-Barberá, M. Pinto, A. Varea, 2022 .

First-year results of the Global Influenza Hospital Surveillance Network: 2012–2013 Northern hemisphere influenza season

A. Sominina, O. Launay, C. Mahé, 2014, BMC Public Health.

MF59®-adjuvanted seasonalinfluenza vaccine

J. Puig-Barberá, 2009 .

Epidemiology of influenza in pregnant women hospitalized with respiratory illness in Moscow, 2012/2013–2015/2016: a hospital-based active surveillance study

E. Burtseva, J. Puig-Barberá, I. Kruzhkova, 2019, BMC Pregnancy and Childbirth.

Efficacy, Immunogenicity and Safety of an Investigational Subunit Adjuvanted Herpes Zoster Vaccine in Adults Aged 60 Years and Older: Results From the ZOE-50 and ZOE-70 Efficacy Studies

Shinn-Jang Hwang, L. Cámpora, M. Levin, 2016 .

Eficacia, efectividad y seguridad de la vacuna antigripal adyuvada en población de 65 o más años de edad

J. M. E. Bouza, J. Puig-Barberá, J. E. Eiros Bouza, 2023, Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia.

Effectiveness of the 2010–2011 seasonal influenza vaccine in preventing confirmed influenza hospitalizations in adults: A case–case comparison, case-control study

A. Arnedo-Pena, V. Gil-Guillén, J. Díez-Domingo, 2012, Vaccine.

Global burden of acute lower respiratory infection associated with human metapneumovirus in children under 5 years in 2018: a systematic review and modelling study

M. Lucero, S. Madhi, K. O'Brien, 2021, The Lancet Global Health.

[Cardiac complications of major elective non-cardiac surgery: incidence and risk factors].

J. Puig-Barberá, S. Márquez-Calderón, Miguel Vila-Sánchez, 2006, Revista espanola de cardiologia.

Influenza vaccine effectiveness in preventing hospitalization among Beijing residents in China, 2013-15.

B. Cowling, P. Yang, Quanyi Wang, 2016, Vaccine.

Genetic characterization of influenza viruses from influenza-related hospital admissions in the St. Petersburg and Valencia sites of the Global Influenza Hospital Surveillance Network during the 2013/14 influenza season.

A. Moya, Grudinin Mp, M. Pisareva, 2016, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Supplemental Digital Content

M. T. Ryan, J. Puig-Barberá, Michael T Ryan, 2013 .